Keywords: gsk, buys, wyeth, vaccines, plant, uk-headquartered, glaxosmithkline
GSK buys Wyeth vaccines plant
Article | 12 September 2005
UK-headquartered GlaxoSmithKline, the world's second-largest drugmaker, has moved deeper into the vaccines business with the acquisition of a research and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
